[1]
“Efficacy of neuroprotective treatment including pyrimidine nucleotides in secondary uveitic glaucoma”, Ukr. j. ophthalmol. , no. 2, pp. 29–33, Jan. 2026, doi: 10.31288/oftalmolzh/2018/2/2933.